英文名稱(chēng) | Salvicine |
---|---|
中文名稱(chēng) | 沙爾威辛 | (±)-沙爾威辛 |
CAS號(hào) | 240423-23-8 |
分子式 | C20H26O4 |
分子量 | 330.42 |
規(guī)格 | 庫(kù)存 | 目錄價(jià) | 會(huì)員專(zhuān)享價(jià) | 數(shù)量 | |
---|---|---|---|---|---|
暫無(wú)牌價(jià)信息,您可以發(fā)送詢(xún)價(jià),我們會(huì)盡快給你回復(fù)。 |
英文名稱(chēng) | Salvicine |
---|---|
中文名稱(chēng) | 沙爾威辛 | (±)-沙爾威辛 |
CAS號(hào) | 240423-23-8 |
分子式 | C20H26O4 |
分子量 | 330.42 |
Salvicine is a natural compound that displays cytotoxicity in human osteosarcoma cells. Salvicine binds to DNA and inhibits the polymerase activity of DNA gyrase, preventing transcription and replication. Salvicine also shows inhibitory effects on the p21 protein, which is an important regulator of G1-phase progression in the cell cycle. Salvicine could be used as a potential drug target for cancer treatment.
Salvicine has antimetastatic activity and shed new light on the complex roles of ROS and downstream signaling molecules, particularly p38 MAPK, in the regulation of integrin function and cell adhesion. Salvicine has potent anti-angiogenic activity through the inhibition on the sequential angiogenic cascades: proliferation, migration and tube formation and is associated with influence on the expression of bFGF of tumor cell.Salvicine inactivates β1 integrin and inhibits integrin-mediated cell adhesion to fibronectin.
Anti-angiogenic activity of salvicine.
PMID: 23750780 DOI: 10.3109/13880209.2013.776612
PMID: 11551518 DOI: 10.1016/s0006-2952(01)00732-8